Donaldson Company DCI Life Sciences Segment — Total Assets
Discontinued — last reported Q1 '26
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Donaldson Company in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The official record: Donaldson Company’s 10-Q, filed December 4, 2025, on SEC EDGAR. View the filing →
Ask your AI about Donaldson Company's life sciences segment — total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Donaldson Company's life sciences segment — total assets?
- Donaldson Company (DCI) reported life sciences segment — total assets of $453M in Q3 2025.
- How has Donaldson Company's life sciences segment — total assets changed year-over-year?
- Donaldson Company's life sciences segment — total assets decreased by 12.5% year-over-year, from $517.8M to $453M.
- What is the long-term trend for Donaldson Company's life sciences segment — total assets?
- Over 2 years (2021 to 2025), Donaldson Company's life sciences segment — total assets has grown at a 271.6% compound annual growth rate (CAGR), from $139.8M to $1.93B.
- What does life sciences segment — total assets mean?
- The total value of all assets dedicated to the Life Sciences segment's operations.
- How do you interpret life sciences segment — total assets?
- Growth in assets relative to sales may indicate capital expansion, while a decline may suggest asset optimization or divestiture.
- How does life sciences segment — total assets compare across companies?
- Used to calculate return on assets (ROA) for the segment; should be benchmarked against industry peers to assess capital intensity.